To hear about similar clinical trials, please enter your email below
Trial Title:
Effect of Compound Amino Acid Tablets on Nutritional Status of Patients With Lung Cancer
NCT ID:
NCT05770063
Condition:
Amino Acid Deficiency
Malnutrition
Lung Cancer
Conditions: Official terms:
Lung Neoplasms
Malnutrition
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Supportive Care
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Intervention:
Intervention type:
Dietary Supplement
Intervention name:
amino acid tablet
Description:
multiple essential amino acids supplements
Arm group label:
control group
Arm group label:
intervention group
Summary:
To investigate whether compound amino acid supplementation can further promote protein
synthesis and improve nutritional status for lung cancer patients.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- NRS2002 >=3 scores
- lung cancer patients
- low albumin or hemoglobin
- informed consent
Exclusion Criteria:
- Acute and critical patients;
- Severe liver and kidney dysfunction;
- Patients with gastrointestinal bleeding or intestinal obstruction;
- Pregnant women, lactating women, people with mental illness, and people without
independent behavior ability.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Start date:
April 15, 2023
Completion date:
August 30, 2023
Lead sponsor:
Agency:
Beijing Chest Hospital
Agency class:
Other
Source:
Beijing Chest Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05770063
